Diana Turner takes a look at drug discovery in India, a country making the shift from scale to innovation. While the Indian pharmaceuticals sector has long held a key global position as a centre for generics development and manufacturing, the country is beginning to make a significant name for itself as a hub for contract research, but […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!